Tirzepatide-RUT is a cutting-edge pharmacological agent High Yield Twincretin designed to mimic the actions of both glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). This dual incretin mimetic exerts its effects by binding to the GLP-1 and GIP receptors, thereby boosting insulin secretion in a glucose-dependent